Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Parkinson's
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Parkinson's
    TopAbstracts in Parkinson's 07/01/2009 - (DGNews)
    Long-Term Use of Prolonged-Release Ropinirole Well Tolerated by Patients With Early or Advanced Parkinson's Disease: Presented at ENS - (DGDispatch)
    Patients Treated With Preladenant for Parkinson's Disease Experience Reduced "Off" Time and Increased "On" Time With No Increase in Dyskinesia: Presented at MDS - (DGDispatch)
    Istradefylline Well Tolerated, Improves Motor Function During "On" State in Patients Receiving Levodopa for Parkinson's Disease: Presented at MDS - (DGDispatch)
    Zonisamide Safe and Effective in Long-Term Treatment of Parkinson's Disease: Presented at MDS - (DGDispatch)

    News archive

     Recent webcasts/CME - Parkinson's
      Initiating and Monitoring Pharmacotherapy in Patients with Parkinson's Disease
      Effective Management in Early Idiopathic Parkinson's Disease
      Case Studies in the Advancement of Parkinson's Disease
      Early Versus Delayed Diagnosis and Treatment of Parkinson's Disease: What You Need to Know
      Managing Parkinson's Disease with Continuous Dopaminergic Stimulation

      Webcasts/CME archive

       Recent cases - Parkinson's
        Pleural Effusion and Pulmonary Hypertension in a Patient With Parkinson Disease Treated With Cabergoline
        Development of Parkinsonism Following Exposure to Aripiprazole: Two Case Reports
        Hypothermia with Osborn Waves in Parkinson's Disease
        HIV, Visceral Leishmaniasis and Parkinsonism Combined with Diabetes Mellitus and Hyperuricaemia: A Case Report
        Gliomatosis Cerebri Presenting as Rapidly Progressive Dementia and Parkinsonism in an Elderly Woman: A Case Report

        Cases archive
          




        my personal edition > parkinson's > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Excessive Hand Force in Parkinson's Disease with Levodopa-Induced Dyskinesias

        A DGReview of :"Force overflow and levodopa-induced dyskinesias in Parkinson's disease"
        Brain

        04/16/2002
        By David Ball


        Levodopa-induced dyskinesias (LID) and grip force excess in patients with Parkinson's disease could well share common pathophysiological mechanisms related to motor fluctuations.

        This is the view of a team of researchers at the Department of Neurology of the Christian-Albrechts Universität Kiel, Germany, who found force excess only in subjects with LID and motor fluctuations.

        Their study of 23 Parkinson's disease patients with LID and 10 without LID, who were compared with age matched healthy controls, assessed the relationship of motor complications of levodopa therapy with force co-ordination of the hand.

        Dyskinesias in those on the drug therapy was found to have a close relationship with the overshooting of forces. Assessments on and off levodopa were made using the motor score of the Unified Parkinson's Disease Rating Scale, a dyskinesia score and force in a grip-lift paradigm.

        The force involved in pressing down the object before lifting by patients with Parkinson's disease + LID was seen to be significantly increased by levodopa (by 61 percent).

        Compared with the off-drug condition, the on-state showed an overshooting of peak grip force by 51 percent (P < 0.05) and of static grip force by 45 percent, whereas no excessive force was seen in Parkinson's disease - LID.

        While peak grip force in on-state was found to be 140 percent higher in Parkinson's disease + LID compared with Parkinson's disease - LID, static grip force increased by 138 percent (P < 0.01) between the groups.

        A strong correlation was found between the severity of peak dose dyskinesias and grip force in on-state (r = 0.79 with peak force).

        There was no apparent correlation between forces and the motor score as well as with the daily dose of dopaminergic medication.
        Brain, April 2002, Vol. 125, No. 4, 871-879. "Force overflow and levodopa-induced dyskinesias in Parkinson's disease"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send